LHAMA and ASTM D-4236: U.S. Labeling Questions for Fluorescent Markers in LED Drawing Board Sets

1. Check the marker's actual U.S. presentation

Art-material scope concerns how a substance is marketed for creating visual or graphic art. A marker supplied in a drawing activity set deserves a specific review rather than being treated as an incidental packing accessory.

The CPSC art-materials FAQ includes markers among examples and explains that packaging, promotion, and intended use matter. Give the responsible U.S. reviewer the full set, marker assortment, intended users, activity instructions, and sales copy. The acrylic surface and the ink are different components; a conclusion about one does not automatically resolve the other. Ask which requirements apply to the actual offer rather than assuming every writing implement follows one route.

Identify whether markers are included with the board, sold as refills, or offered in a separate retail pack. Keep those presentations visible because the user, exposure, quantity, and claims can differ. The importer should confirm scope with qualified U.S. product and toxicological advice where needed. The factory's role is to provide accurate formulation and product information through a suitable confidential process, not to make an unsupported blanket legal claim.

Use a full-set reference such as the Panda LED Fluorescent Board and confirm which marker assortment is actually proposed. A product image can help identify components but does not establish formulation or U.S. labeling status. Ask the supplier to connect each marker reference to the records available for qualified review, including any separately sold refill offer the brand intends to launch.

• Review the marker's actual art-use presentation.
• Include full set, refill, and separate-pack offers.
• Assign the U.S. scope and labeling review to responsible parties.

2. Identify the formulation behind each marker reference

A barrel shape, color name, or supplier catalog code does not necessarily establish formulation identity. The evidence file should connect the proposed marker to the actual formulation and supplier records used in the review.

Ask which controlled reference identifies the ink formulation, color, marker body and tip, manufacturer, and pack. Some information may need to go directly from the formulation owner to a qualified reviewer under confidentiality arrangements. The buyer should know that this transfer occurred and which product the review covers without demanding that trade secrets be posted in public marketing or shared indiscriminately across the supply chain.

Do not infer that all colors share the same assessment merely because they are sold as one assortment. Ask the reviewer how the assortment is represented and what formulation or exposure information is needed. Retain the resulting scope description, product references, and labeling recommendations. That record is more useful than a photograph of a generic non-toxic logo or a report for a marker made by another supplier.

The formulation owner and importer can agree a confidential disclosure process with the qualified reviewer. Document the transfer, product references, and resulting scope without publishing proprietary ingredient details unnecessarily. If the supplier cannot identify the actual formulation or reviewer coverage, keep the evidence task open. A non-disclosure arrangement should enable the appropriate review rather than become a reason to replace it with a generic assurance.

• Use controlled formulation and product references.
• Arrange confidential technical disclosure where appropriate.
• Confirm how the supplied color assortment is represented.

3. Obtain the appropriate chronic-hazard review

CPSC describes toxicological review obligations for art materials and identifies the producer, importer, or repackager as responsible. Confirm the current requirements and obtain advice from a qualified reviewer for the actual formulation and use.

Ask what the review covers and what label it supports

The current regulatory text and CPSC resources should guide the responsible business. Ask the reviewer to identify the formulation, package and use presentation, information considered, relevant findings, and required labeling. A review should be traceable to the actual proposed marker rather than a general statement about water-based inks or fluorescent colors.

Keep this work separate from a board's electrical report, a marker's functional wipe test, or an unrelated chemical screening. Each can provide useful evidence for a particular question, but none should be renamed to fill another requirement. The buyer's project tracker should identify missing records and the person responsible for obtaining them before U.S. artwork is released.

Ask the reviewer which physical and chemical information is needed for the actual use and packaging. A larger refill pack, a different tip, or a new presentation can raise questions that should be evaluated from the facts. The buyer should provide the intended offer honestly and ask for a labeling recommendation with a clear scope, rather than asking the reviewer to endorse predetermined marketing language.

• Use current official requirements and qualified review.
• Match the assessment to formulation and presentation.
• Keep toxicological, chemical-screening, and functional records distinct.

4. Approve label wording and placement from the evidence

A conformance statement or cautionary label should follow the applicable U.S. requirements and qualified review. Do not add familiar wording to a carton simply because another marker pack displays it.

CPSC explains conformance-statement and hazard-labeling topics in its official guidance. The responsible importer should confirm the exact wording and permitted placement for the proposed product. Review the marker barrel, immediate package, board carton, insert, and any other relevant presentation together. A small retail set can have limited space, but space constraints should be resolved through the applicable rules rather than by shrinking important information until it is unreadable.

Keep the approved labeling recommendation, final artwork, product references, and production proof in one file. A graphic designer should receive the released wording and instructions for use, not be asked to invent safety text. If a label references a formulation, assortment, or market version, ensure the factory and packing team can distinguish it from similar products. Confirm current label requirements with the responsible U.S. reviewer before printing.

A printed conformance statement must be attached to a real evidence decision. The artwork approver should verify the released wording, product reference, and placement with the responsible U.S. party. A designer can check typography and layout, but should not infer legal permission from a competitor's pack. Keep the final proof and the reviewer's applicable recommendations in the same project index.

• Use evidence-supported wording and permitted placement.
• Review all relevant pack levels.
• Control final artwork and product references together.

5. Treat non-toxic wording as a separate substantiation question

A functional drawing demonstration cannot establish toxicological safety. Any non-toxic or similar claim should be assessed for its evidence, meaning, and suitability for the actual marker and market.

A marker can write smoothly and wipe cleanly while still needing appropriate hazard assessment and labeling. Conversely, a functional residue issue does not establish a toxicological conclusion. Ask the qualified reviewer what the actual assessment supports and have the responsible business approve any consumer-facing claim. Avoid turning an absence of visible odor or a supplier's casual assurance into a claim about health or environmental safety.

Use the marker compatibility protocol for the practical pen-and-panel task. Keep that protocol's findings limited to the defined surface, ink, dwell, and care conditions. The marketing team should receive the approved claim boundaries so a short product title does not broaden the scope of an assessment. The full board set and intended age may also need separate review.

Keep claims such as washable, odorless, non-toxic, and suitable for a particular age as separate entries in the claims register. They can involve different meanings and evidence needs. A functional trial can support a narrow observation about one task, while a qualified assessment addresses another question. The marketing team should know which statements are approved, what they concern, and which proposed benefits remain unsubstantiated.

• Separate functional observations from health claims.
• Approve wording against the actual evidence.
• Give marketing a clear claim scope.

6. Check additional children's-product and toy obligations

Art-material review does not automatically complete every requirement for a children's drawing-board set. The U.S. responsible party should assess applicable children's-product, toy, tracking, testing, and certification obligations.

Provide the complete marketed set and age presentation to the reviewer, including markers, caps, acrylic panel, base, power parts, packaging, and instructions. Ask which requirements apply to each component and the product as a whole. The U.S. market-entry preparation guide can help organize the wider file. It should be used with current official sources and qualified product-specific advice.

Do not call one art-material review a complete toy approval or assume a children's-product certificate resolves every labeling task. The responsible business should identify each required deliverable and its issuer or signer. Keep permanent product and packaging identifiers aligned with the actual production records. If the product includes optional items, clarify whether they are part of the supplied set and review them accordingly before release.

Caps, tips, ink, barrels, the acrylic surface, and the electrical base may all belong in different parts of a children's-product assessment. Provide the full set and intended activity so the qualified reviewer can identify applicable work. Do not assume that a marker's art-material record completes requirements for the cap or the whole toy. A component map makes these boundaries practical for procurement and quality teams.

• Assess the complete set and age presentation.
• List additional testing, labeling, and certification tasks.
• Keep component and whole-product evidence connected.

7. Maintain formulation change and review records

A change to formula or component supply can affect the review. Establish a notice process and ask the qualified reviewer how current requirements apply to reevaluation and ongoing manufacture.

Require the marker supplier to disclose relevant formulation, component-source, color, and pack changes through the agreed confidential channel. Record the old and new references and the effective production date. The responsible reviewer should determine what evidence or label changes are needed. Do not let purchasing accept an unreviewed substitute simply because the price and barrel color are similar.

At reorder, verify that the reviewed marker is the one being packed. Factory testing can check component identity, color assortment, and defined writing observations, while shipment inspection can reconcile contents and released artwork. Neither process independently repeats the toxicological review. Keep the records available for customer or retailer questions and monitor applicable review intervals using current CPSC guidance rather than relying on an indefinitely reused certificate image.

A periodic file review should confirm the marker supplier, controlled formulation references, current assortment, packaging, and any changes since the last assessment. Ask the responsible reviewer to track required review intervals and reevaluation triggers under current guidance. Purchasing should not approve a new source solely because the replacement looks the same or has the same commercial color name as an earlier marker.

• Require notice of formulation and source changes.
• Connect review scope to production dates and references.
• Verify the packed assortment and artwork at reorder.

8. Conclusion: qualify the marker as a product component

For a U.S. drawing-board offer, the marker needs its own identity, review, and label plan alongside the complete set. Do not let the visual appeal of illuminated ink hide an incomplete evidence file.

A clear supplier request identifies the proposed markers, presentation, intended users, confidential technical-review route, and required labeling records. It also defines how changes will be handled. This gives the importer a practical basis for deciding what is ready and what remains open. The process should be proportionate to the actual product while preserving the distinction between sample observations and regulatory or toxicological conclusions.

For LumDigi, share your intended U.S. product offer, age presentation, marker assortment, refill plan, and importer or retailer requirements. We can confirm the proposed supplied components and identify available factual records. Your responsible U.S. parties and qualified reviewers should determine art-material scope, labeling, and the wider children's-product obligations for the exact configuration.

At shipment, reconcile the released marker references and color assortment with the contents list and artwork. Record the inspection's limited scope and preserve findings. A factory functional check or packing audit does not repeat a toxicological assessment. The value of this stage is confirming that the product shipped is the one the responsible parties actually reviewed and intended to place on the market.

• Identify markers and full-set presentation.
• Obtain appropriate qualified review and label advice.
• Control formulation and packing changes before release.